Screening the Entity Is Not Enough

Profile

• Industry: Investment management
• Location: Singapore (MAS-regulated)
• Focus: Multi-layered screening across entity and UBO
• Solution: Prudexis AI Compliance Agent
• Principle: Screening stops at the entity only if the risk stops at the entity.

The Gap in Most Screening Programmes

When a corporate investor onboards, most compliance programmes screen the entity. The company name goes through the watchlist. No hits, no problem. Onboarding proceeds.

The problem is that sanctions, PEP designations, and financial crime risk rarely attach to corporate names. They attach to people. And the people who control, own, and benefit from corporate structures are not always visible at the entity level.

MAS Notice SFA04-N02 and MAS Notice 626 are explicit on this point. Firms must identify and verify the beneficial owners of corporate customers and their AML/CFT obligations extend to those individuals, not just the entity that holds the account.

Genuine compliance requires looking through the structure.

What Multi-Layered Screening Means in Practice

Prudexis screens at every layer of the corporate structure relevant to the investor relationship.

• Layer 1, entity screening: the corporate investor is screened against configured watchlist sources and adverse media.
• Layer 2, UBO screening: each identified beneficial owner is screened independently using the same workflow and interface.
• Layer 3, agent review: all entity and UBO hits are assessed in a single job, with per-hit rationale and recommendation.
• Layer 4, human decision: compliance officers review the agent assessment and confirm disposition in the audit trail.

Why UBO Screening Changes the Risk Picture

A corporate structure with clean entity-level screening can still present significant risk at the UBO level.

• An offshore investment vehicle with no adverse entity history, whose controlling UBO is a designated individual operating under a transliterated name variant.
• A fund with multiple UBOs, one of whom becomes a PEP after onboarding and is only surfaced at periodic rescreening.
• A corporate investor whose UBO shares a common name with a sanctioned individual, requiring precise identity verification.

Without UBO-level screening, the entity clears and the risk remains.

The risk does not disappear because the corporate name is clean. The screening programme has to go to where the risk actually lives.

The Agent's Role in Making This Tractable

UBO screening multiplies the volume of potential hits. A corporate investor with four UBOs generates four times the screening surface.

Prudexis reviews all hits in a single agent job, evaluates identity-distinguishing factors, and produces a structured summary with per-hit rationale.

False positives are documented and dismissible. Genuine matches are surfaced with supporting evidence, reducing manual cross-referencing to a focused review process.

The Full Stack

Multi-layered screening in Prudexis is part of the same connected workflow that covers CDD review, policy-grounded checklists, and risk ratings.

Entity and UBO hits appear in the same screening tab, reviewed in the same interface, with a single audit trail from agent rationale to analyst confirmation.

One investor. Multiple layers. One workflow. One audit trail.

The Broader Point

The key compliance question is not just whether the investor was screened. It is whether everyone who presents risk in connection with that investor was screened.

For corporate investors, that means both the entity and the people behind it: UBOs identified and screened at onboarding, then rescreened as watchlists update.

Screening the entity is where compliance starts. The UBO layer is where it actually matters.

"Screening the company name was never enough. The risk lives with the people behind it. Now we can actually show we looked."